Intellectual Property, Patent, Trademark & Copyright Law Updates

HB Ad Slot
HB Mobile Ad Slot

Intellectual property applies to many different areas of the legal world. Applying for patents for work-products, by individual employees, trademark laws, copyrights, and how companies leverage their IP asset-rights over employees, are just a few of the many areas the National Law Review covers as it pertains to IP.

Intellectual Property Litigation

Intellectual Property disputes are a complex area of law, often involving deep dives into complex concepts to understand the issues at play. In the United States, the United States Patent and Trademark Office (USPTO/PTO) is the agency involved in registering patents and trademarks.   As part of the USPTO, the Patent Trial and Appeal Board settles patent disputes, using a variety of mechanisms to settle issues related to intellectual property.    Some of the mechanisms include inter partes review, post-grant procedures, and covered business method patent reviews.  Issues related to the America Invents Act are also settled through the PTAB. The National Law Review covers changes to standards held by the USPTO in litigation and other patent issues.  The Trademark Trial and Appeal Board settles disputes related to trademarks, such as an ex parte appeal from the denial of an application for registration by an examining attorney, and an inter partes opposition, cancellation, concurrent use, or interference proceeding.  Other agencies involved in patent disputes are the International Trade Commission (ITC) or the Federal Trade Commission (FTC).  The National Law Review covers patent news as it relates to Supreme Court (SCOTUS) and federal circuit courts’ appeals, as well as general patent litigation and new patent filings.

Intellectual Property in Drug Patents

Legal analysis related to drug patents and pharmaceuticals and the interplay with intellectual property issues are also covered by the National Law Review.   Drug patents, biosimilars, generic top-level domain registration (gTLD), trade secrets, non-compete clauses, and other patent application news are updated on the site regularly. Additionally, tangential issues that impact pharmaceutical companies, such as innovator liability and related litigation, are also analyzed by the legal experts who write for the National Law Review. 

Intellectual Property in an Employment Context

The National Law Review has legal analysis on the intersection between intellectual property rights and employment, and who owns ideas, the Work Made For Hire principle as well resulting litigation. Additionally, legislation such as the Defense of Trade Secrets Act and its impact on workplaces, and ongoing litigation related to the legislation is also covered.

International Intellectual Property

Visitors to the site will oftentimes read about international news as it relates to patent applications in the US, and internationally as well. Pharmaceutical patents in Brazil, medical device patent applications from the United Kingdom, or litigation from the European Union, China, India, and other international sectors, are often covered online. Visitors will find the latest coverage, news, and insights on patent applications and litigation, when visiting the National Law Review, for up-to-date practice-area news.

National Law Review Intellectual Property/Patent Law TwitterFor hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Recent Intellectual Property, Patent, Trademark & Copyright News

Title
Custom text Organization
Jul
22
2024
Supreme Court Doesn’t Want to Play the Name Game: Prohibition Against Using a Person’s Name in a Registered Mark Without Consent Remains Constitutional Mintz
Jul
20
2024
Chinese Utility Model Grants Continue Slide in First Half of 2024 Schwegman, Lundberg & Woessner, P.A.
Jul
19
2024
USPTO Issues New Guidance on Patent Subject Matter Eligibility for AI Inventions Greenberg Traurig, LLP
Jul
19
2024
Like a Tree Falling that No One Hears: AI-Generated Disclosures Have the Potential to Block Patentability of Human Ingenuity Squire Patton Boggs (US) LLP
Jul
19
2024
IP Assignment Agreements: Protecting Your Company Today and Saving Yourself from Headaches Tomorrow Winstead
Jul
19
2024
Relying on Noncompete Clauses May Not Be the Best Defense of Proprietary Data When Employees Depart Wilson Elser Moskowitz Edelman & Dicker LLP
Jul
19
2024
China’s Supreme People’s Court Fines Litigant 1 Million RMB for Destroying Evidence in Violation of Court-Ordered Evidence Preservation Schwegman, Lundberg & Woessner, P.A.
Jul
18
2024
Federal Circuit Provides Insight on Induced Infringement Claims in Amarin Pharma Inc. v. Hikma Pharmaceuticals USA Inc. Sheppard, Mullin, Richter & Hampton LLP
Jul
18
2024
Bipartisan Group of Senators Introduce Bill to Address AI Deepfakes and Protect Intellectual Property – AI: The Washington Report Mintz
Jul
18
2024
House Rules: Remote Gambling Activity Claims Go Bust McDermott Will & Emery
Jul
18
2024
PTO Asks Whether Legislative Action for Experimental Use Exception Is Warranted McDermott Will & Emery
Jul
18
2024
It’s an Old Tune: Third-Party-Use Evidence From Long Ago Can Support Genericness McDermott Will & Emery
Jul
18
2024
Message Received: Trade Secret Law Damages Available for Sales Outside US McDermott Will & Emery
Jul
18
2024
European UPC Issues Its First Decisions on the Merits McDermott Will & Emery
Jul
18
2024
Golden State of Mind: Anti-SLAPP Defense Versus Privacy Rights McDermott Will & Emery
Jul
18
2024
Smart Choice: Survey Design Didn’t Render Survey Unreliable McDermott Will & Emery
Jul
18
2024
Assessing the Impact of Recent Supreme Court Decisions on ITC Practice – Less than Meets the Eye? Mintz
Jul
17
2024
The FTC’s Challenge to the Listing of Device Patents in the Orange Book: What Challenge? Polsinelli PC
Jul
17
2024
USPTO Clarifies Patent-Eligibility Guidelines for AI Inventions Foley & Lardner LLP
Jul
17
2024
Preliminary Injunction Halts Sales of Tumor-Informed Cancer Screening Test Bradley Arant Boult Cummings LLP
Jul
17
2024
USPTO Issues Updated Guidance on Patent Subject Matter Eligibility and AI Womble Bond Dickinson (US) LLP
Jul
17
2024
China’s Supreme People’s Court Rules in First Patent Preliminary Injunction Case Schwegman, Lundberg & Woessner, P.A.
Jul
16
2024
China’s National Intellectual Property Administration Releases More Details on Open Licensing Schwegman, Lundberg & Woessner, P.A.
Jul
16
2024
USPTO Issues AI Subject Matter Eligibility Guidance Sheppard, Mullin, Richter & Hampton LLP
Jul
16
2024
Supreme Court Clarifies Limits on Freedom of Expression under the Lanham Act Wilson Elser Moskowitz Edelman & Dicker LLP
Jul
16
2024
Patenting Power Plays For AI Drug Discovery Foley & Lardner LLP
Jul
15
2024
Litigating Trade Secrets in Biotech, Life Sciences, and AI: The High-Stakes Battle Over Clinical Trial Innovations Proskauer Rose LLP
Jul
12
2024
Trademark Insights: What the First Precedential TTAB Expungement Decision Means for You Womble Bond Dickinson (US) LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins